USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $-0.36 | $-0.40 | $-0.33 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $13.80M | $6.74M | $3.60M |
Aveo Pharmaceuticals's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $-0.20 | $-0.26 | $-0.12 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $-1.68 | $-1.77 | $-1.58 |
| Dec 2022 | 4 | $-0.17 | $-0.68 | $0.32 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.20 | $-0.31 | $-0.31 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-1.68 | $-1.90 | $-1.90 |
| Dec 2022 | 0 / 0 | $-0.17 | $-0.16 | $-0.16 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $22.40M | $18.51M | $27.15M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $45.66M | $40.32M | $54.98M |
| Dec 2022 | 4 | $130.27M | $93.78M | $188.58M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $-0.36 | - | - |
| Aug 5, 2021 | Jun 2021 | $-0.50 | $-0.40 | 19.60% |
| May 10, 2021 | Mar 2021 | $-0.55 | $-0.81 | -47.95% |
| Mar 16, 2021 | Dec 2020 | $-0.38 | $-0.44 | -15.79% |
| Nov 9, 2020 | Sep 2020 | $-0.23 | $-0.33 | -45.05% |
| Aug 10, 2020 | Jun 2020 | $-0.61 | $-0.42 | 30.58% |
| Apr 30, 2020 | Mar 2020 | $-0.50 | $-0.52 | -4.69% |
| Mar 16, 2020 | Dec 2019 | $-0.58 | $-0.28 | 51.45% |
| Nov 12, 2019 | Sep 2019 | $0.30 | $1.00 | 233.33% |
| Aug 8, 2019 | Jun 2019 | $-0.65 | $-0.20 | 69.23% |
| May 9, 2019 | Mar 2019 | $-0.55 | $0.04 | 107.64% |
| Mar 14, 2019 | Dec 2018 | $-0.55 | $1.80 | 427.27% |
| Nov 9, 2018 | Sep 2018 | $-0.63 | $-1.80 | -184.23% |
| Aug 7, 2018 | Jun 2018 | $-0.63 | $0.30 | 147.37% |
| May 8, 2018 | Mar 2018 | $-0.70 | $-0.80 | -14.29% |
| Mar 13, 2018 | Dec 2017 | $-0.30 | $0.27 | 189.67% |
| Nov 7, 2017 | Sep 2017 | $-0.50 | $-2.20 | -340.00% |
| Aug 9, 2017 | Jun 2017 | $-0.90 | $-3.00 | -233.33% |
| May 4, 2017 | Mar 2017 | $-1.20 | $-1.20 | - |
| Mar 22, 2017 | Dec 2016 | $-1.20 | $-0.70 | 41.67% |
| Nov 4, 2016 | Sep 2016 | $-1.15 | $-0.70 | 39.13% |
| Aug 4, 2016 | Jun 2016 | $-1.40 | $-1.14 | 18.79% |
| May 10, 2016 | Mar 2016 | $-1.30 | $-1.30 | - |
| Mar 15, 2016 | Dec 2015 | $-0.04 | $-0.11 | -175.00% |
| Nov 9, 2015 | Sep 2015 | $-0.09 | $0.14 | 255.56% |
| Aug 10, 2015 | Jun 2015 | $-0.20 | $-0.10 | 50.00% |
| May 7, 2015 | Mar 2015 | $-0.24 | $-0.21 | 12.50% |
| Mar 6, 2015 | Dec 2014 | $-0.21 | $-0.27 | -28.57% |
| Nov 5, 2014 | Sep 2014 | $-0.23 | $-0.28 | -21.74% |
| Aug 11, 2014 | Jun 2014 | $-0.44 | $-0.35 | 20.45% |
| May 7, 2014 | Mar 2014 | $-4.02 | $-1.20 | 70.15% |
| Mar 13, 2014 | Dec 2013 | $-3.25 | $-3.20 | 1.54% |
| Nov 7, 2013 | Sep 2013 | $-4.71 | $-4.70 | 0.21% |
| Aug 8, 2013 | Jun 2013 | $-5.61 | $-4.70 | 16.22% |
| Apr 29, 2013 | Mar 2013 | $-7.19 | $-6.90 | 4.03% |
| Feb 13, 2013 | Dec 2012 | $-7.69 | $-4.30 | 44.08% |
| Oct 30, 2012 | Sep 2012 | $-8.66 | $-6.90 | 20.32% |
| Aug 2, 2012 | Jun 2012 | $-8.91 | $-6.80 | 23.68% |
| May 3, 2012 | Mar 2012 | $-7.61 | $-7.70 | -1.18% |
| Feb 14, 2012 | Dec 2011 | $-6.12 | $-5.80 | 5.23% |
| Nov 2, 2011 | Sep 2011 | $-5.50 | $-5.50 | - |
| Jul 28, 2011 | Jun 2011 | $-7.52 | $-1.60 | 78.72% |
| Apr 28, 2011 | Mar 2011 | $-5.67 | $22.80 | 502.12% |
| Feb 16, 2011 | Dec 2010 | $-6.42 | $-3.00 | 53.27% |
| Nov 4, 2010 | Sep 2010 | $-6.17 | $-6.00 | 2.76% |
| Jul 29, 2010 | Jun 2010 | $-3.50 | $-5.00 | -42.86% |
| Apr 29, 2010 | Mar 2010 | $-7.00 | $-6.90 | 1.43% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 16, 2021 | Dec 2020 | $-1.60 | $-1.71 | - |
| Mar 16, 2020 | Dec 2019 | $0.32 | $0.56 | 75.63% |
| Mar 14, 2019 | Dec 2018 | $-0.28 | $-0.50 | - |
| Mar 13, 2018 | Dec 2017 | $-0.66 | $-6.13 | - |
| Mar 22, 2017 | Dec 2016 | - | $-3.84 | - |
| Mar 15, 2016 | Dec 2015 | - | $-0.28 | - |
| Mar 6, 2015 | Dec 2014 | - | $-2.10 | - |
| Mar 13, 2014 | Dec 2013 | - | $-19.50 | - |
| Feb 13, 2013 | Dec 2012 | - | $-25.70 | - |
| Feb 14, 2012 | Dec 2011 | - | $9.90 | - |
| Feb 16, 2011 | Dec 2010 | - | $-20.90 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $13.80M | - | - |
| Aug 5, 2021 | Jun 2021 | $8.94M | $6.74M | 0.75% |
| May 10, 2021 | Mar 2021 | $1.01M | $1.92M | 1.90% |
| Mar 16, 2021 | Dec 2020 | $3.00M | $886.00K | 0.30% |
| Nov 9, 2020 | Sep 2020 | $2.77M | $3.60M | 1.30% |
| Aug 10, 2020 | Jun 2020 | $1.35M | $749.00K | 0.55% |
| Apr 30, 2020 | Mar 2020 | $1.83M | $784.00K | 0.43% |
| Mar 16, 2020 | Dec 2019 | $2.05M | $764.00K | 0.37% |
| Nov 12, 2019 | Sep 2019 | $10.94M | $25.72M | 2.35% |
| Aug 8, 2019 | Jun 2019 | $2.71M | $703.00K | 0.26% |
| May 9, 2019 | Mar 2019 | $2.16M | $1.61M | 0.75% |
| Mar 14, 2019 | Dec 2018 | $2.40M | $1.48M | 0.62% |
| Nov 9, 2018 | Sep 2018 | $680.00K | $2.47M | 3.63% |
| Aug 7, 2018 | Jun 2018 | $1.35M | $433.00K | 0.32% |
| May 8, 2018 | Mar 2018 | $1.65M | $1.03M | 0.62% |
| Mar 13, 2018 | Dec 2017 | $1.25M | $82.00K | 0.07% |
| Nov 7, 2017 | Sep 2017 | - | $4.61M | - |
| Aug 9, 2017 | Jun 2017 | - | $351.00K | - |
| May 4, 2017 | Mar 2017 | - | $2.53M | - |
| Mar 22, 2017 | Dec 2016 | - | $127.00K | - |
| Nov 4, 2016 | Sep 2016 | - | $992.00K | - |
| Aug 4, 2016 | Jun 2016 | - | $193.00K | - |
| May 10, 2016 | Mar 2016 | - | $1.20M | - |
| Mar 15, 2016 | Dec 2015 | - | $3.60M | - |
| Nov 9, 2015 | Sep 2015 | - | $15.16M | - |
| Aug 10, 2015 | Jun 2015 | - | $134.00K | - |
| May 7, 2015 | Mar 2015 | - | $134.00K | - |
| Mar 6, 2015 | Dec 2014 | - | $116.00K | - |
| Nov 5, 2014 | Sep 2014 | - | $873.00K | - |
| Aug 11, 2014 | Jun 2014 | - | $1.85M | - |
| May 7, 2014 | Mar 2014 | - | $15.29M | - |
| Mar 13, 2014 | Dec 2013 | - | $323.00K | - |
| Nov 7, 2013 | Sep 2013 | - | $323.00K | - |
| Aug 8, 2013 | Jun 2013 | - | $324.00K | - |
| Apr 29, 2013 | Mar 2013 | - | $323.00K | - |
| Feb 13, 2013 | Dec 2012 | - | $15.53M | - |
| Oct 30, 2012 | Sep 2012 | - | $1.02M | - |
| Aug 2, 2012 | Jun 2012 | - | $1.88M | - |
| May 3, 2012 | Mar 2012 | - | $860.00K | - |
| Feb 14, 2012 | Dec 2011 | - | $1.10M | - |
| Nov 2, 2011 | Sep 2011 | - | $3.58M | - |
| Jul 28, 2011 | Jun 2011 | - | $26.55M | - |
| Apr 28, 2011 | Mar 2011 | - | $133.61M | - |
| Feb 16, 2011 | Dec 2010 | - | $11.96M | - |
| Nov 4, 2010 | Sep 2010 | - | $6.22M | - |
| Jul 29, 2010 | Jun 2010 | - | $15.62M | - |
| Apr 29, 2010 | Mar 2010 | - | $10.88M | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 16, 2021 | Dec 2020 | $8.12M | $6.02M | -25.87% |
| Mar 16, 2020 | Dec 2019 | $30.07M | $28.80M | -4.24% |
| Mar 14, 2019 | Dec 2018 | $5.77M | $5.41M | -6.26% |
| Mar 13, 2018 | Dec 2017 | $11.10M | $7.58M | -31.72% |
| Mar 22, 2017 | Dec 2016 | - | $2.52M | - |
| Mar 15, 2016 | Dec 2015 | - | $19.02M | - |
| Mar 6, 2015 | Dec 2014 | - | $18.12M | - |
| Mar 13, 2014 | Dec 2013 | - | $1.29M | - |
| Feb 13, 2013 | Dec 2012 | - | $19.29M | - |
| Feb 14, 2012 | Dec 2011 | - | $164.85M | - |
| Feb 16, 2011 | Dec 2010 | - | $44.68M | - |
AVEO's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.
According to 4 analysts, the average EPS estimation for Aveo Pharmaceuticals's next quarterly earnings is $-0.36, with a low EPS estimation of $-0.40, and a high estimation of $-0.29.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.36, the last 2 month trend is $-0.40, and the 3 month trend is $-0.40.
Based on 4 analysts, the average revenue estimation is $13.80M, with a low revenue estimation of $11.00M, and a high estimation of $18.36M.
Aveo Pharmaceuticals's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.
AVEO's earnings per share (EPS) was $-0.40, beating the consensus analysts forecast of $-0.50 by 19.60%.
The EPS was higher than the previous fiscal quarter (Mar 2021) by -50.62%, and higher than the same period a year before (Jun 2020) by -4.76%.
Revenues were $6.74M, worse than the forecast of $8.94M by -24.66%, up by 250.78% from the previous quarter , and up by 799.20% from the same period last year.
The company reported a net income of $-13.60M.Free cash flow for the quarter was $-37.00M , compared to $-18.33M last quarter and $-7.53M a year before.
AVEO ended the quarter with $473.00K in total debt, a decrease of -98.57% compared to the previous quarter, and a decrease of -95.75% compared to the same quarter a year before.
Aveo Pharmaceuticals's previous annual earnings date was Mar 16, 2021 for its fiscal year ended Dec 31, 2020.
AVEO's earnings per share (EPS) was $-1.71, missing the consensus analysts forecast of $-1.60 by 6.87% , and lower than the previous year's EPS (Dec 2019) by -404.27%.
Revenues were $6.02M, worse than the forecast of $8.12M by -25.87%, and down by -79.10% from previous year's revenue.
The company reported a net income of $-35.58M.
Aveo Pharmaceuticals reported a free cash flow of $-38.35M for its fiscal year, compared to $-2.92M a year ago.
The company ended the fiscal year with $14.14M in total debt, a decrease of -10.31% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
